| Symbol |
Name |
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AR
|
androgen receptor
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CD5
|
CD5 molecule
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CITED4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
E4F1
|
E4F transcription factor 1
|
|
FHL2
|
four and a half LIM domains 2
|
|
FHL3
|
four and a half LIM domains 3
|
|
FOXO1
|
forkhead box O1
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IL1B
|
interleukin 1, beta
|
|
ITGA7
|
integrin, alpha 7
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PTK2
|
protein tyrosine kinase 2
|
|
RNF111
|
ring finger protein 111
|
|
SIRT1
|
sirtuin 1
|
|
SMAD4
|
SMAD family member 4
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
TCF3
|
transcription factor 3
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TP53
|
tumor protein p53
|
|
TTN
|
titin
|
|
VEGFA
|
vascular endothelial growth factor A
|